KYMERA THERAPEUTICS, INC. (KYMR) Operating cash flow 2019–2025
KYMERA THERAPEUTICS, INC. (KYMR) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$232.9MFY2025 · since FY2019: $17.9M → -$232.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$232.9M | -19.7% |
| FY2024 | -$194.5M | -89.2% |
| FY2023 | -$102.8M | +32.8% |
| FY2022 | -$153.1M | -18.7% |
| FY2021 | -$128.9M | -246.3% |
| FY2020 | $88.1M | +392.2% |
| FY2019 | $17.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More KYMR financial trends
KYMR RevenueKYMR Net incomeKYMR Net marginKYMR Gross profitKYMR Gross marginKYMR Operating incomeKYMR Operating marginKYMR Free cash flowKYMR Capital expendituresKYMR Return on equityKYMR Stock buybacksKYMR Dividends paidKYMR Total assetsKYMR Total liabilitiesKYMR Shareholders’ equityKYMR overview →